Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells

An obstacle to developing a vaccine against human respiratory syncytial virus (RSV) is that natural infection typically does not confer solid immunity to reinfection. To investigate methods to augment the immune response, recombinant RSV (rRSV) was constructed that expresses murine granulocyte-macro...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bukreyev, Alexander, Belyakov, Igor M., Berzofsky, Jay A., Murphy, Brian R., Collins, Peter L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2001
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC116109/
https://ncbi.nlm.nih.gov/pubmed/11711604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.24.12128-12140.2001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires